Scientific Advisory Board

Julian Adams, PhD

CEO at Gamida Cell, former Head of R&D at Infinity, and SVP of Drug Discovery at Millennium Pharmaceuticals, expert in signal transduction

Ross Camidge, MD, PhD

Director of Thoracic Oncology Program, Professor of Medicine-Medical Oncology at University of Colorado, authority in targeted therapies for lung cancer

Channing Der, PhD

Professor of Pharmacology at the Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, expert in RAS signaling

 

Daniel Von Hoff, MD

Physician in Chief, Distinguished Professor at the Translational Genomics Research Institute; CSO of US Oncology and Professor of Medicine at the Mayo Clinic, innovator in the development of multiple cancer therapies